Poniard Pharmaceuticals (Poniard Pharmaceuticals) EV-to-FCF : 0.00 (As of Apr. 29, 2024)

Poniard Pharmaceuticals EV-to-FCF Chart

Poniard Pharmaceuticals Annual Data
	Trend	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10
EV-to-FCF		Get a 7-Day Free Trial					-3.28	-2.34	-0.58	-1.52	-0.93

Poniard Pharmaceuticals Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Poniard Pharmaceuticals's EV-to-FCF

For the Biotechnology subindustry, Poniard Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's EV-to-FCF falls into.

Poniard Pharmaceuticals EV-to-FCF Calculation

Poniard Pharmaceuticals's EV-to-FCF for today is calculated as:

Poniard Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Poniard Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals  (OTCPK:PARD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Poniard Pharmaceuticals's PE Ratio for today is calculated as:

Poniard Pharmaceuticals's share price for today is $0.0001.
Poniard Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Poniard Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Poniard Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Poniard Pharmaceuticals (Poniard Pharmaceuticals) Business Description